{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:18:48Z","timestamp":1783700328243,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Canopy Growth Corporation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This Phase I randomized controlled trial aimed to assess the safety and tolerability of cannabidiol (CBD) and alcohol co-administration among moderate alcohol consumers in acute laboratory and chronic outpatient settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Healthy adults ages 21\u201365 with moderate alcohol use completed three acute dosing sessions where they received either placebo, 50 mg CBD, or 100 mg CBD along with alcohol dosed to achieve peak blood alcohol concentrations (BAC) of 0.06 g\/100 mL. Sessions were randomly ordered, and participants and outcome assessors were blinded to study drug during these laboratory sessions. Breath alcohol content (BrAC) and measures of subjective effects and impairment were collected from participants throughout each session. Participants then consumed 50 mg CBD twice daily for four weeks as outpatients while reporting alcohol use, craving, and adverse effects via a smartphone app. Metabolic labs and CBD content were measured from blood samples collected at four-week follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-nine participants were enrolled and nineteen participants completed the study. CBD was well-tolerated in both acute and chronic dosing sessions. Acute CBD-alcohol use was not associated with significant differences in subjective responses or breath alcohol content (BrAC) peak or time course compared to placebo for either CBD condition. Acute CBD-alcohol use was not associated with impairment 4\u00a0h after dosing. CBD use was not associated with significant changes in alcohol cravings or drinks per day, nor significant lab changes outside of decreases in protein and globulin, across the chronic dosing period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CBD co-administration with alcohol was not associated with significant changes in subjective or physiologic effects among moderate alcohol consumers in acute laboratory and naturalistic outpatient settings. The safety of CBD use in patients with more severe alcohol use should be examined in future studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      This study was registered at ClinicalTrials.gov on April 7th, 2022 under the code\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT05317507?a=5\" ext-link-type=\"uri\">NCT05317507<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-026-00457-1","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:05:12Z","timestamp":1781327112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of Co-Administered Cannabidiol (CBD) and alcohol: a Phase I study"],"prefix":"10.1186","volume":"8","author":[{"given":"David","family":"Wolinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Blaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica N.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise M.","family":"Weerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel O.","family":"Bonn-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"457_CR1","unstructured":"2022 S. National Survey on Drug Use and Health (2022) detailed tables. 2023. Available from: https:\/\/www.samhsa.gov\/data\/report\/2022-nsduh-detailed-tables."},{"key":"457_CR2","volume-title":"Psychological testing","author":"A Anastasi","year":"1969","unstructured":"Anastasi A. Psychological testing. New York: MacMillan; 1969."},{"issue":"4","key":"457_CR3","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.pbb.2010.11.013","volume":"97","author":"ME Ballard","year":"2011","unstructured":"Ballard ME, de Wit H. Combined effects of acute, very-low-dose ethanol and delta (9)-tetrahydrocannabinol in healthy human volunteers. Pharmacol Biochem Behav. 2011;97(4):627\u201331.","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"457_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF00496070","volume":"64","author":"BE Belgrave","year":"1979","unstructured":"Belgrave BE, Bird KD, Chesher GB, Jackson DM, Lubbe KE, Starmer GA, et al. The effect of cannabidiol, alone and in combination with ethanol, on human performance. Psychopharmacology (Berl). 1979;64(2):243\u20136.","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"457_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/jat\/bkab124","volume":"46","author":"CL Bergeria","year":"2022","unstructured":"Bergeria CL, Spindle TR, Cone EJ, Sholler D, Goffi E, Mitchell JM, et al. Pharmacokinetic profile of \u22069-tetrahydrocannabinol, cannabidiol and metabolites in blood following vaporization and oral ingestion of cannabidiol products. J Anal Toxicol. 2022;46(6):583\u201391.","journal-title":"J Anal Toxicol"},{"key":"457_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF00434409","volume":"71","author":"K Bird","year":"1980","unstructured":"Bird K, Boleyn T, Chesher G, Jackson D, Starmer G, Teo R. Intercannabinoid and cannabinoid-ethanol interactions and their effects on human performance. Psychopharmacology. 1980;71:181\u20138.","journal-title":"Psychopharmacology"},{"issue":"5","key":"457_CR7","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/adb.12665","volume":"24","author":"SK Blaine","year":"2019","unstructured":"Blaine SK, Nautiyal N, Hart R, Guarnaccia J, Sinha R. Craving, cortisol and behavioral alcohol motivation responses to stress and alcohol cue contexts and discrete cues in binge and non-binge drinkers. Addict Biol. 2019;24(5):1096\u2013108.","journal-title":"Addict Biol"},{"issue":"3","key":"457_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1530-0277.1995.tb01554.x","volume":"19","author":"MJ Bohn","year":"1995","unstructured":"Bohn MJ, Krahn DD, Staehler BA. Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res. 1995;19(3):600\u20136.","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"457_CR9","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.3390\/ijms25042370","volume":"25","author":"S Chen","year":"2024","unstructured":"Chen S, Kim JK. The role of cannabidiol in liver disease: a systemic review. Int J Mol Sci. 2024;25(4):2370.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"457_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1037\/0022-006X.53.2.189","volume":"53","author":"RL Collins","year":"1985","unstructured":"Collins RL, Parks GA, Marlatt GA. Social determinants of alcohol consumption: the effects of social interaction and model status on the self-administration of alcohol. J Consult Clin Psychol. 1985;53(2):189.","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"457_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF00431988","volume":"66","author":"P Consroe","year":"1979","unstructured":"Consroe P, Carlini EA, Zwicker AP, Lacerda LA. Interaction of cannabidiol and alcohol in humans. Psychopharmacology. 1979;66(1):45\u201350.","journal-title":"Psychopharmacology"},{"issue":"21","key":"457_CR12","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017;376(21):2011\u201320.","journal-title":"N Engl J Med"},{"issue":"20","key":"457_CR13","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","volume":"378","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, et al. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med. 2018;378(20):1888\u201397.","journal-title":"N Engl J Med"},{"issue":"3","key":"457_CR14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41386-025-02164-6","volume":"51","author":"S Dirik","year":"2026","unstructured":"Dirik S, Doyle MR, Wood CP, Campo P, Martinez AR, Fannon M, et al. Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum. Neuropsychopharmacology. 2026;51(3):691\u2013702.","journal-title":"Neuropsychopharmacology"},{"key":"457_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/bs.pmbts.2019.06.005","volume":"167","author":"S Elsaid","year":"2019","unstructured":"Elsaid S, Kloiber S, Le Foll B. Effects of cannabidiol (CBD) in neuropsychiatric disorders: a review of pre-clinical and clinical findings. Prog Mol Biol Transl Sci. 2019;167:25\u201375.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"9","key":"457_CR16","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3390\/molecules24091694","volume":"24","author":"LE Ewing","year":"2019","unstructured":"Ewing LE, Skinner CM, Quick CM, Kennon-McGill S, McGill MR, Walker LA, et al. Hepatotoxicity of a cannabidiol-rich cannabis extract in the mouse model. Molecules. 2019;24(9):1694.","journal-title":"Molecules"},{"issue":"8","key":"457_CR17","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","volume":"23","author":"B Flannery","year":"1999","unstructured":"Flannery B, Volpicelli J, Pettinati H. Psychometric properties of the Penn alcohol craving scale. Alcohol Clin Exp Res. 1999;23(8):1289\u201395.","journal-title":"Alcohol Clin Exp Res"},{"issue":"9","key":"457_CR18","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jamainternmed.2025.2366","volume":"185","author":"J Florian","year":"2025","unstructured":"Florian J, Salcedo P, Burkhart K, Shah A, Chekka LMS, Keshishi D, et al. Cannabidiol and liver enzyme level elevations in healthy adults: a randomized clinical trial. JAMA Intern Med. 2025;185(9):1070\u20138.","journal-title":"JAMA Intern Med"},{"key":"457_CR19","doi-asserted-by":"crossref","unstructured":"Freisthler B, Thurston H, Price Wolf J. Examining the context of cannabis use and parenting: an exploratory ecological momentary assessment study. Parenting. 2026;26(2):192\u2013212.","DOI":"10.1080\/15295192.2024.2394656"},{"issue":"6","key":"457_CR20","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s11606-022-07948-w","volume":"38","author":"PD Gon\u00e7alves","year":"2023","unstructured":"Gon\u00e7alves PD, Levy NS, Segura LE, Bruzelius E, Boustead AE, Hasin DS, et al. Cannabis recreational legalization and prevalence of simultaneous cannabis and alcohol use in the United States. J Gen Intern Med. 2023;38(6):1493\u2013500.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"457_CR21","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41386-018-0050-8","volume":"43","author":"G Gonzalez-Cuevas","year":"2018","unstructured":"Gonzalez-Cuevas G, Martin-Fardon R, Kerr TM, Stouffer DG, Parsons LH, Hammell DC, et al. Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle. Neuropsychopharmacology. 2018;43(10):2036\u201345.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"457_CR22","first-page":"04","volume":"42","author":"RL Gunn","year":"2022","unstructured":"Gunn RL, Aston ER, Metrik J. Patterns of cannabis and alcohol co-use: substitution versus complementary effects. Alcohol Res. 2022;42(1):04.","journal-title":"Alcohol Res"},{"key":"457_CR23","volume-title":"Brain and intelligence","author":"WC Halstead","year":"1947","unstructured":"Halstead WC. Brain and intelligence. Chicago: University of Chicago Press; 1947."},{"issue":"6","key":"457_CR24","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1373\/clinchem.2015.238287","volume":"61","author":"RL Hartman","year":"2015","unstructured":"Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney G, et al. Controlled cannabis vaporizer administration: blood and plasma cannabinoids with and without alcohol. Clin Chem. 2015;61(6):850\u201369.","journal-title":"Clin Chem"},{"key":"457_CR25","doi-asserted-by":"publisher","first-page":"113778","DOI":"10.1016\/j.fct.2023.113778","volume":"176","author":"RG Henderson","year":"2023","unstructured":"Henderson RG, Lefever TW, Heintz MM, Trexler KR, Borghoff SJ, Bonn-Miller MO. Oral toxicity evaluation of cannabidiol. Food Chem Toxicol. 2023a;176:113778.","journal-title":"Food Chem Toxicol"},{"key":"457_CR26","doi-asserted-by":"publisher","first-page":"105482","DOI":"10.1016\/j.yrtph.2023.105482","volume":"144","author":"RG Henderson","year":"2023","unstructured":"Henderson RG, Vincent M, Rivera BN, Bonn-Miller MO, Doepker C. Cannabidiol safety considerations: development of a potential acceptable daily intake value and recommended upper intake limits for dietary supplement use. Regul Toxicol Pharmacol. 2023b;144:105482.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"4","key":"457_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/jama.2025.19433","volume":"335","author":"M Hsu","year":"2026","unstructured":"Hsu M, Shah A, Jordan A, Gold MS, Hill KP. Therapeutic use of cannabis and cannabinoids: a review. JAMA. 2026;335(4):345\u201359.","journal-title":"JAMA"},{"issue":"9258","key":"457_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0140-6736(00)04170-2","volume":"357","author":"A Imhof","year":"9258","unstructured":"Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 9258;357(9258):763\u20137.","journal-title":"Lancet"},{"key":"457_CR29","doi-asserted-by":"publisher","first-page":"724747","DOI":"10.3389\/fphar.2021.724747","volume":"12","author":"X Jiang","year":"2021","unstructured":"Jiang X, Gu Y, Huang Y, Zhou Y, Pang N, Luo J, et al. CBD alleviates liver injuries in alcoholics with high-fat high-cholesterol diet through regulating NLRP3 inflammasome\u2013pyroptosis pathway. Front Pharmacol. 2021;12:724747.","journal-title":"Front Pharmacol"},{"issue":"1","key":"457_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","volume":"28","author":"IG Karniol","year":"1974","unstructured":"Karniol IG, Shirakawa I, Kasinski N, Pfeferman A, Carlini EA. Cannabidiol interferes with the effects of \u03949-tetrahydrocannabinol in man. Eur J Pharmacol. 1974;28(1):172\u20137.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"457_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/acer.14256","volume":"44","author":"HC Karoly","year":"2020","unstructured":"Karoly HC, Mueller RL, Bidwell LC, Hutchison KE. Cannabinoids and the microbiota-gut-brain axis: emerging effects of cannabidiol and potential applications to alcohol use disorders. Alcohol Clin Exp Res. 2020;44(2):340\u201353.","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"457_CR32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1037\/adb0000706","volume":"35","author":"H Karoly","year":"2021","unstructured":"Karoly H, Mueller R, Andrade C, Hutchison K. THC and CBD effects on alcohol use among alcohol and cannabis co-users. Psychol Addict Behav. 2021;35(6):749.","journal-title":"Psychol Addict Behav"},{"issue":"1","key":"457_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/can.2020.0048","volume":"7","author":"HC Karoly","year":"2022","unstructured":"Karoly HC, Milburn MA, Brooks-Russell A, Brown M, Streufert J, Bryan AD, et al. Effects of high-potency cannabis on psychomotor performance in frequent cannabis users. Cannabis Cannabinoid Res. 2022;7(1):107\u201315.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"5","key":"457_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00213-023-06349-z","volume":"240","author":"HC Karoly","year":"2023","unstructured":"Karoly HC, Drennan ML, Prince MA, Zulic L, Dooley G. Consuming oral cannabidiol prior to a standard alcohol dose has minimal effect on breath alcohol level and subjective effects of alcohol. Psychopharmacology. 2023;240(5):1119\u201329.","journal-title":"Psychopharmacology"},{"issue":"1","key":"457_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000531666","volume":"6","author":"R Kaufmann","year":"2023","unstructured":"Kaufmann R, Harris Bozer A, Jotte AK, Aqua K. Long-term, self-dosing CBD users: indications, dosage, and self-perceptions on general health\/symptoms and drug use. Med Cannabis Cannabinoids. 2023;6(1):77\u201388.","journal-title":"Med Cannabis Cannabinoids"},{"issue":"3","key":"457_CR36","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0168-8278(91)90846-4","volume":"12","author":"CS Lieber","year":"1991","unstructured":"Lieber CS, Decarli LM. Hepatotoxicity of ethanol. J Hepatol. 1991;12(3):394\u2013401.","journal-title":"J Hepatol"},{"issue":"6","key":"457_CR37","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/joim.13627","volume":"293","author":"LA Lo","year":"2023","unstructured":"Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, et al. Cannabidiol-associated hepatotoxicity: a systematic review and meta-analysis. J Intern Med. 2023;293(6):724\u201352.","journal-title":"J Intern Med"},{"issue":"2","key":"457_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0376-8716(01)00118-1","volume":"64","author":"SE Lukas","year":"2001","unstructured":"Lukas SE, Orozco S. Ethanol increases plasma \u03949-tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteers. Drug Alcohol Depend. 2001;64(2):143\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"457_CR39","doi-asserted-by":"publisher","first-page":"e48954","DOI":"10.2196\/48954","volume":"8","author":"A Luken","year":"2024","unstructured":"Luken A, Rabinowitz JA, Wells JL, Sosnowski DW, Strickland JC, Thrul J, et al. Designing and validating a novel method for assessing delay discounting associated with health behaviors: ecological momentary assessment study. JMIR Form Res. 2024;8(1):e48954.","journal-title":"JMIR Form Res"},{"issue":"1","key":"457_CR40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1530-0277.1993.tb00739.x","volume":"17","author":"CS Martin","year":"1993","unstructured":"Martin CS, Earleywine M, Musty RE, Perrine M, Swift RM. Development and validation of the biphasic alcohol effects scale. Alcohol Clin Exp Res. 1993;17(1):140\u20136.","journal-title":"Alcohol Clin Exp Res"},{"key":"457_CR41","doi-asserted-by":"crossref","unstructured":"Metrik J, Aston E, Gunn RL, Swift R, MacKillop J, Kahler CW, Acute effects of cannabis on alcohol craving and consumption: a randomized controlled crossover trial. Am J Psychiatry.\u00a02026;183(2):134\u201343.","DOI":"10.1176\/appi.ajp.20250115"},{"issue":"5","key":"457_CR42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","volume":"77","author":"I Miller","year":"2020","unstructured":"Miller I, Scheffer IE, Gunning B, Sanchez-Carpintero R, Gil-Nagel A, Perry MS, et al. Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet syndrome: a randomized clinical trial. JAMA Neurol. 2020;77(5):613\u201321.","journal-title":"JAMA Neurol"},{"issue":"1","key":"457_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s42238-021-00061-5","volume":"3","author":"J Moltke","year":"2021","unstructured":"Moltke J, Hindocha C. Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems. J Cannabis Res. 2021;3(1):5.","journal-title":"J Cannabis Res"},{"key":"457_CR44","doi-asserted-by":"publisher","first-page":"109829","DOI":"10.1016\/j.drugalcdep.2023.109829","volume":"245","author":"CF Moore","year":"2023","unstructured":"Moore CF, Zamarripa CA, Weerts EM. Oral cannabidiol does not alter alcohol seeking and self-administration in baboons. Drug Alcohol Depend. 2023;245:109829.","journal-title":"Drug Alcohol Depend"},{"key":"457_CR45","first-page":"31","volume":"5","author":"J Richman","year":"2019","unstructured":"Richman J, May S. An investigation of the Druid\u00ae smartphone\/tablet app as a rapid screening assessment for cognitive and psychomotor impairment associated with alcohol intoxication. Vis Dev Rehabil. 2019;5:31\u201342.","journal-title":"Vis Dev Rehabil"},{"key":"457_CR46","doi-asserted-by":"crossref","unstructured":"Roman Y. The United States 2020 census data: implications for precision medicine and the research landscape. Taylor & Francis; 2022. p. 5-8.","DOI":"10.2217\/pme-2021-0129"},{"issue":"3","key":"457_CR47","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2466\/pr0.1974.34.3.1003","volume":"34","author":"SA Sack","year":"1974","unstructured":"Sack SA, Rice CE. Selectivity, resistance to distraction and shifting as three attentional factors. Psychol Rep. 1974;34(3):1003\u201312.","journal-title":"Psychol Rep"},{"issue":"3","key":"457_CR48","first-page":"148","volume":"20","author":"NR Schultz","year":"2020","unstructured":"Schultz NR, Junkin E, Correia CJ. The effect of intoxication on free-pour accuracy following skills training. Behav Anal Res Pract. 2020;20(3):148.","journal-title":"Behav Anal Res Pract"},{"issue":"1","key":"457_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, et al. Alcoholic liver disease. Nat Rev Dis Primers. 2018;4(1):16.","journal-title":"Nat Rev Dis Primers"},{"key":"457_CR50","doi-asserted-by":"publisher","first-page":"209472","DOI":"10.1016\/j.josat.2024.209472","volume":"166","author":"LA Shrier","year":"2024","unstructured":"Shrier LA, McCaskill NH, Smith MC, O\u2019Connell MM, Gluskin BS, Parker S, et al. Telehealth counseling plus mHealth intervention for cannabis use in emerging adults: development and a remote open pilot trial. J Subst Use Addict Treat. 2024;166:209472.","journal-title":"J Subst Use Addict Treat"},{"key":"457_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-072348","author":"M Solmi","year":"2023","unstructured":"Solmi M, De Toffol M, Kim JY, Choi MJ, Stubbs B, Thompson T, et al. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies. BMJ. 2023. https:\/\/doi.org\/10.1136\/bmj-2022-072348.","journal-title":"BMJ"},{"issue":"12","key":"457_CR52","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1111\/acer.12581","volume":"38","author":"PA Spagnolo","year":"2014","unstructured":"Spagnolo PA, Ramchandani VA, Schwandt ML, Zhang L, Blaine SK, Usala JM, et al. Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients. Alcohol Clin Exp Res. 2014;38(12):3024\u201332.","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"457_CR53","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/02698811211021583","volume":"35","author":"TR Spindle","year":"2021","unstructured":"Spindle TR, Martin EL, Grabenauer M, Woodward T, Milburn MA, Vandrey R. Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis. J Psychopharmacol. 2021;35(7):786\u2013803.","journal-title":"J Psychopharmacol"},{"key":"457_CR54","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","volume":"32","author":"L Taylor","year":"2018","unstructured":"Taylor L, Gidal B, Blakey G, Tayo B, Morrison G. A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects. CNS Drugs. 2018;32:1053\u201367.","journal-title":"CNS Drugs"},{"issue":"4","key":"457_CR55","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/acer.13964","volume":"43","author":"J Turna","year":"2019","unstructured":"Turna J, Syan SK, Frey BN, Rush B, Costello MJ, Weiss M, et al. Cannabidiol as a novel candidate alcohol use disorder pharmacotherapy: a systematic review. Alcohol Clin Exp Res. 2019;43(4):550\u201363.","journal-title":"Alcohol Clin Exp Res"},{"issue":"16","key":"457_CR56","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1111\/bph.14380","volume":"175","author":"A Viudez-Mart\u00ednez","year":"2018","unstructured":"Viudez-Mart\u00ednez A, Garc\u00eda-Guti\u00e9rrez MS, Fraguas-S\u00e1nchez AI, Torres-Su\u00e1rez AI, Manzanares J. Effects of cannabidiol plus naltrexone on motivation and ethanol consumption. Br J Pharmacol. 2018a;175(16):3369\u201378.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"457_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/adb.12495","volume":"23","author":"A Viudez-Mart\u00ednez","year":"2018","unstructured":"Viudez-Mart\u00ednez A, Garc\u00eda-Guti\u00e9rrez MS, Navarr\u00f3n CM, Morales-Calero MI, Navarrete F, Torres-Su\u00e1rez AI, et al. Cannabidiol reduces ethanol consumption, motivation and relapse in mice. Addict Biol. 2018b;23(1):154\u201364.","journal-title":"Addict Biol"},{"issue":"1","key":"457_CR58","doi-asserted-by":"publisher","first-page":"12064","DOI":"10.1038\/s41598-017-10924-8","volume":"7","author":"Y Wang","year":"2017","unstructured":"Wang Y, Mukhopadhyay P, Cao Z, Wang H, Feng D, Hask\u00f3 G, et al. Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury. Sci Rep. 2017;7(1):12064.","journal-title":"Sci Rep"},{"issue":"12","key":"457_CR59","doi-asserted-by":"publisher","first-page":"e2347373-e","DOI":"10.1001\/jamanetworkopen.2023.47373","volume":"6","author":"AR Wilson-Poe","year":"2023","unstructured":"Wilson-Poe AR, Smith T, Elliott MR, Kruger DJ, Boehnke KF. Past-year use prevalence of cannabidiol, cannabigerol, cannabinol, and \u03948-tetrahydrocannabinol among US adults. JAMA Netw Open. 2023;6(12):e2347373-e.","journal-title":"JAMA Netw Open"},{"key":"457_CR60","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2013.12.026","volume":"68","author":"L Yang","year":"2014","unstructured":"Yang L, Rozenfeld R, Wu D, Devi LA, Zhang Z, Cederbaum A. Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. Free Radic Biol Med. 2014;68:260\u20137.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"457_CR61","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s40429-017-0149-8","volume":"4","author":"AM Yurasek","year":"2017","unstructured":"Yurasek AM, Aston ER, Metrik J. Co-use of alcohol and cannabis: a review. Curr Addict Rep. 2017;4(2):184\u201393.","journal-title":"Curr Addict Rep"},{"key":"457_CR62","doi-asserted-by":"publisher","first-page":"964749","DOI":"10.3389\/fphar.2022.964749","volume":"13","author":"CA Zamarripa","year":"2022","unstructured":"Zamarripa CA, Novak MD, Weerts EM, Vandrey R, Spindle TR. The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: a two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol. Front Pharmacol. 2022;13:964749.","journal-title":"Front Pharmacol"},{"issue":"6","key":"457_CR64","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/s41380-024-02869-y","volume":"30","author":"S Zimmermann","year":"2025","unstructured":"Zimmermann S, Teetzmann A, Bae\u00dfler J, Schreckenberger L, Zaiser J, Pfisterer M, et al. Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial. Mol Psychiatry. 2025;30(6):2612\u20139.","journal-title":"Mol Psychiatry"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-026-00457-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00457-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00457-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:02:36Z","timestamp":1783699356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42238-026-00457-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["457"],"URL":"https:\/\/doi.org\/10.1186\/s42238-026-00457-1","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were conducted in accordance with the International Conference on Harmonization Good Clinical Practice Guidelines, the Declaration of Helsinki, and local laws and regulations. The protocol was approved by the Auburn University Institutional Review Board (IRB #20221017). Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JS has received research related funding from Canopy Growth Corporation and DynamiCare Health and consulting fees from Realm of Care Foundation and Merck Corporation in the past three years. EW has received research support from Canopy Growth Corporation for clinical research projects unrelated to this study and from has received funds from MyMD Pharmaceuticals, Mira1a Pharmaceuticals, Cultivate Biologics for research unrelated to this study. AH is a former employee of Canopy Growth Corporation. ENP received stock options as an employee of Canopy Growth Corporation during execution of study. MBM is an employee of Charlotte\u2019s Web, a member of the Board of Directors at DeFloria, and a former employee of Canopy Growth Corporation. To address these conflicts of interest, Sara Blaine, an investigator at Auburn University without current or former connections to Canopy Growth, was permitted to oversee the study administration and data collection in addition to assisting with study design. The raw data were sent to JHU investigators for independent data curation and analyses. Additionally, the primary responsibilities for interpreting results and drafting the manuscript were held by David Wolinsky, who has no conflicts of interest. Moreover, Canopy Growth Corporation were not permitted to have rights to determine the ability or interpretation of published data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}